H.R. 3433: Give Kids a Chance Act of 2024

The bill focuses on improving pediatric cancer treatment by amending the Federal Food, Drug, and Cosmetic Act to support clinical trials of new drug combinations. It aims to enhance the development of molecularly targeted therapies for pediatric cancers, ensuring that studies are designed to yield meaningful clinical outcomes for young patients. It also extends priority review vouchers for rare pediatric diseases to encourage pharmaceutical companies to develop treatments​. Learn more…